MRSA

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\MRSA.php on line 2
MRSA

LE WE PMID CA

MRSA

1844

MRSA

Aids

Bacteria (Resistance mechanisms)

Bacteria (Taxonomy)

Ceftobiprole

CNS (Infection)

Fomites

Hospital infection control

Infection control and surveillance

Lemierre s syndrome

Lung (Pneumonia BASKET)

MRSA

Mupirocin

ORL (Pharyngitis)

Panton Valentine leukocidin

Retapamulin

Rifampin

Soft tissues (Infection)

Staphylococcus aureus

2009 1	Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations. [19675746] Ger Med Sci 7(-): Doc06 (2009)
2006 2	High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. [17060545] Arch Intern Med 166(19): 2138-44 (2006)
2004 3	Methicillin resistant Staphylococcus aureus in the critically ill. [14665563] Br J Anaesth 92(1): 121-30 (2004)
2005 4	Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections? [15987417] Crit Care 9(3): 257-8 (2005)
2009 5	New antimicrobial agents for methicillin-resistant Staphylococcus aureus. [20001879] Crit Care Resusc 11(4): 282-6 (2009)
2003 6	Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. [14636487] Health Technol Assess 7(39): 1-194 (2003)
2009 7	Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge. [19470504] Antimicrob Agents Chemother 53(10): 4051-63 (2009)
2009 8	Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia. [19596879] Antimicrob Agents Chemother 53(9): 3894-901 (2009)
1989 9	Methicillin-resistant staphylococci: detection methods and treatment of infections. [2675760] Antimicrob Agents Chemother 33(7): 995-9 (1989)
1989 10	Methicillin-resistant staphylococci: genetics and mechanisms of resistance. [2675759] Antimicrob Agents Chemother 33(7): 991-4 (1989)
2009 11	Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia? [19744984] J Antimicrob Chemother 64(5): 1111-3 (2009)
2009 12	Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. [19451132] J Antimicrob Chemother 64(1): 9-15 (2009)
2008 13	Intranasal mupirocin for reduction of Staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. [18174201] J Antimicrob Chemother 61(2): 254-61 (2008)
2008 14	The effect of antibiotics on methicillin-resistant Staphylococcus aureus. [18057071] J Antimicrob Chemother 61(2): 246-53 (2008)
2006 15	Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. [16507559] J Antimicrob Chemother 57(4): 589-608 (2006)
1997 16	Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. [9336672] Clin Microbiol Rev 10(4): 781-91 (1997)
1997 17	Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. [9227864] Clin Microbiol Rev 10(3): 505-20 (1997)
1988 18	Methicillin-resistant staphylococci. [3069195] Clin Microbiol Rev 1(2): 173-86 (1988)
2008 19	Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. [18322065] J Clin Microbiol 46(5): 1577-87 (2008)
2009 20	New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus. [19951334] Clin Microbiol Infect 15 Suppl 7(-): 44-52 (2009)
2009 21	Do guidelines for the prevention and control of methicillin-resistant Staphylococcus aureus make a difference? [19951333] Clin Microbiol Infect 15 Suppl 7(-): 39-43 (2009)
2009 22	Methicillin-resistant Staphylococcus aureus: source control and surveillance organization. [19951332] Clin Microbiol Infect 15 Suppl 7(-): 31-8 (2009)
2009 23	Methicillin-resistant Staphylococcus aureus in long-term-care facilities. [19951331] Clin Microbiol Infect 15 Suppl 7(-): 26-30 (2009)
2009 24	Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know? [19951330] Clin Microbiol Infect 15 Suppl 7(-): 17-25 (2009)
2009 25	Methods for screening for methicillin-resistant Staphylococcus aureus carriage. [19951329] Clin Microbiol Infect 15 Suppl 7(-): 10-6 (2009)
2009 26	Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it. [19951328] Clin Microbiol Infect 15 Suppl 7(-): 2-9 (2009)
2009 27	Management of methicillin-resistant Staphylococcus aureus infections. [19291144] Clin Microbiol Infect 15(2): 125-36 (2009)
2009 28	Prevention and control of methicillin-resistant Staphylococcus aureus. [19291143] Clin Microbiol Infect 15(2): 120-4 (2009)
2009 29	Laboratory tools and strategies for methicillin-resistant Staphylococcus aureus screening, surveillance and typing: state of the art and unmet needs. [19291142] Clin Microbiol Infect 15(2): 112-9 (2009)
2009 30	New insights concerning methicillin-resistant Staphylococcus aureus disease. [19291141] Clin Microbiol Infect 15(2): 109-11 (2009)
2008 31	Methicillin-resistant Staphylococcus aureus: risk assessment and infection control policies. [18190564] Clin Microbiol Infect 14(5): 407-10 (2008)
2008 32	New and emerging treatment of Staphylococcus aureus infections in the hospital setting. [18318877] Clin Microbiol Infect 14 Suppl 3(-): 32-41 (2008)
2007 33	National guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus--what do they tell us? [17608744] Clin Microbiol Infect 13(9): 846-53 (2007)
2007 34	The molecular evolution of methicillin-resistant Staphylococcus aureus. [17391376] Clin Microbiol Infect 13(3): 222-35 (2007)
2006 35	Control of endemic methicillin-resistant Staphylococcus aureus--recent advances and future challenges. [17121620] Clin Microbiol Infect 12(12): 1154-62 (2006)
2005 36	Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy. [15997484] Clin Microbiol Infect 11 Suppl 4(-): 33-42 (2005)
2005 37	Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to prevent hospital-acquired MRSA infections. [15882195] Clin Microbiol Infect 11(6): 457-65 (2005)
2008 38	Pathogenesis of methicillin-resistant Staphylococcus aureus infection. [18462090] Clin Infect Dis 46 Suppl 5(-): S350-9 (2008)
1995 39	Molecular evolution of MRSA. [7494490] Microbiol Immunol 39(8): 531-43 (1995)
2010 40	Revisiting Methicillin-Resistant Staphylococcus aureus Infections. [20300418] J Glob Infect Dis 2(1): 49-56 (2010)
2009 41	How does healthcare worker hand hygiene behaviour impact upon the transmission of MRSA between patients?: an analysis using a Monte Carlo model. [19445655] BMC Infect Dis 9(-): 64 (2009)
2001 42	Molecular epidemiology of methicillin-resistant Staphylococcus aureus. [11294733] Emerg Infect Dis 7(2): 323-6 (2001)
2008 43	Methicillin-resistant Staphylococcus aureus: a primer for dentists. [18832268] J Am Dent Assoc 139(10): 1328-37 (2008)
2008 44	Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. [18283202] Ann Intern Med 148(4): 249-57 (2008)
2006 45	The growing menace of community-acquired methicillin-resistant Staphylococcus aureus. [16520479] Ann Intern Med 144(5): 368-70 (2006)
2006 46	Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen? [17035421] Chest 130(4): 938-40 (2006)
2008 47	Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. [18310398] Eur Respir J 31(3): 625-32 (2008)
2005 48	Methicillin-resistant Staphylococcus aureus: past, present, and--too much of a--future. [15792269] Isr Med Assoc J 7(3): 194-6 (2005)
2009 49	Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. [19729844] J Clin Invest 119(9): 2464-74 (2009)
2007 50	Methicillin-resistant Staphylococcus aureus: the latest health scare. [18053452] Mayo Clin Proc 82(12): 1463-7 (2007)
2005 51	Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. [16178500] Mayo Clin Proc 80(9): 1201-7; quiz 1208 (2005)
2002 52	Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. [12151652] Postgrad Med J 78(921): 385-92 (2002)
2005 53	External ocular infections due to methicillin-resistant Staphylococcus aureus (MRSA). [15375372] Eye (Lond) 19(3): 284-91 (2005)
2010 54	Serious infections caused by methicillin-resistant Staphylococcus aureus. [20731576] Clin Infect Dis 51 Suppl 2(-): S183-97 (2010)
2010 55	Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. [20731575] Clin Infect Dis 51 Suppl 2(-): S176-82 (2010)
2010 56	Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus? [20662715] Clin Infect Dis 51(5): 585-90 (2010)
2010 57	Prevention and control of methicillin-resistant Staphylococcus aureus: dealing with reality, resistance, and resistance to reality. [20001538] Clin Infect Dis 50(2): 218-20 (2010)
2007 58	Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. [17712745] Clin Infect Dis 45 Suppl 3(-): S184-90 (2007)
2007 59	Reading the tea leaves or deciphering DNA microarrays: are certain methicillin-resistant Staphylococcus aureus clones adapted to cause specific infections? [17243051] Clin Infect Dis 44(4): 502-5 (2007)
2009 60	Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review. [19231978] Clin Infect Dis 48(7): 922-30 (2009)
2008 61	Ceftobiprole: a new option for treatment of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus. [18225983] Clin Infect Dis 46(5): 656-8 (2008)
2008 62	Clinical practice: colonization, fomites, and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. [18220477] Clin Infect Dis 46(5): 752-60 (2008)
2008 63	Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection. [18444820] Clin Infect Dis 46(7): 1032-7 (2008)
2008 64	Management of methicillin-resistant Staphylococcus aureus bacteremia. [18462094] Clin Infect Dis 46 Suppl 5(-): S386-93 (2008)
2008 65	Pneumonia caused by methicillin-resistant Staphylococcus aureus. [18462093] Clin Infect Dis 46 Suppl 5(-): S378-85 (2008)
2008 66	Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. [18462092] Clin Infect Dis 46 Suppl 5(-): S368-77 (2008)
2008 67	Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. [18462091] Clin Infect Dis 46 Suppl 5(-): S360-7 (2008)
2008 68	The use of active surveillance cultures in adult intensive care units to reduce methicillin-resistant Staphylococcus aureus-related morbidity, mortality, and costs: a systematic review. [18494098] Clin Infect Dis 46(11): 1717-25 (2008)
2008 69	Fact, fiction, or no data: what does surveillance for methicillin-resistant Staphylococcus aureus prevent in the intensive care unit? [18462112] Clin Infect Dis 46(11): 1726-8 (2008)
2009 70	Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. [19725789] Clin Infect Dis 49(7): 1072-9 (2009)
2009 71	Mupirocin resistance. [19673644] Clin Infect Dis 49(6): 935-41 (2009)
2008 72	Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection. [18197761] Clin Infect Dis 46(4): 584-93 (2008)
2007 73	An outbreak of severe infections with community-acquired MRSA carrying the Panton-Valentine leukocidin following vaccination. [17786194] PLoS One 2(9): e822 (2007)
2007 74	Antibiotic resistant Staphylococcus aureus: a paradigm of adaptive power. [17921044] Curr Opin Microbiol 10(5): 428-35 (2007)
2008 75	Clones and drones: do variants of Panton-Valentine leukocidin extend the reach of community-associated methicillin-resistant Staphylococcus aureus? [18177251] J Infect Dis 197(2): 175-8 (2008)
2008 76	Understanding the success of methicillin-resistant Staphylococcus aureus strains causing epidemic disease in the community. [18173362] J Infect Dis 197(2): 179-82 (2008)
2010 77	Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. [20610826] Clin Microbiol Rev 23(3): 616-87 (2010)
2010 78	Rifampin combination therapy for nonmycobacterial infections. [20065324] Clin Microbiol Rev 23(1): 14-34 (2010)
2007 79	Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin? [17547497] Expert Rev Anti Infect Ther 5(3): 333-5 (2007)
2007 80	Community-associated MRSA: a dangerous epidemic. [17927464] Future Microbiol 2(5): 457-9 (2007)
2008 81	Who's winning the war? [18829723] J Antimicrob Chemother 62 Suppl 3(-): iii3-6 (2008)
2005 82	Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA). [16293678] J Antimicrob Chemother 56(6): 1000-18 (2005)
2008 83	Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. [17986491] J Antimicrob Chemother 61(1): 26-38 (2008)
2008 84	Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. [18339633] J Antimicrob Chemother 61(5): 976-94 (2008)
2009 85	Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. [19608582] J Antimicrob Chemother 64(3): 441-6 (2009)
2008 86	Methicillin-resistant Staphylococcus aureus infections. [19106430] Top HIV Med 16(5): 151-5 (2008)
2010 87	Molecular diagnostics and genotyping of MRSA: an update. [20465491] Expert Rev Mol Diagn 10(4): 375-80 (2010)
2010 88	Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. [20961515] Euro Surveill 15(41): 19688 (2010)
2003 89	Molecular techniques for MRSA typing: current issues and perspectives. [12807690] Braz J Infect Dis 7(1): 32-43 (2003)
2010 90	Methicillin resistant Staphylococcus aureus: knowledge and factors related to the nursing teams adherence to preventive measures. [20721422] Rev Lat Am Enfermagem 18(3): 346-51 (2010)
2009 91	Molecular pathogenesis of Staphylococcus aureus infection. [19190527] Pediatr Res 65(5 Pt 2): 71R-77R (2009)
2011 92	Staphylococcal cassette chromosome mec (Sccmec) classification and typing methods: an overview. [21905625] Pol J Microbiol 60(2): 95-103 (2011)
2011 93	In vitro activity of retapamulin against linezolid and methicillin-resistant Staphylococcus aureus isolates. [21947094] Rev Esp Quimioter 24(3): 127-30 (2011)
2002 94	Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. [11969119] Sci Prog 85(Pt 1): 57-72 (2002)
2008 95	Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. [18271763] J Am Acad Nurse Pract 20(2): 85-92 (2008)
2011 96	Methicillin-resistant Staphylococcus aureus USA300 clone as a cause of Lemierre's syndrome. [21430106] J Clin Microbiol 49(5): 2063-6 (2011)
2010 97	Transmission of methicillin-resistant Staphylococcus aureus to household contacts. [19923490] J Clin Microbiol 48(1): 202-7 (2010)
2007 98	Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. [17146447] Lab Invest 87(1): 3-9 (2007)
2007 99	Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. [17724154] Antimicrob Agents Chemother 51(11): 3880-6 (2007)
2009 100	VanA-type vancomycin-resistant Staphylococcus aureus. [19506057] Antimicrob Agents Chemother 53(11): 4580-7 (2009)
2010 101	Screening methods for meticillin-resistant Staphylococcus aureus. [20634333] J Med Microbiol 59(Pt 10): 1153-5 (2010)
2009 102	Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus. [19528145] J Med Microbiol 58(Pt 9): 1247-51 (2009)
2010 103	Methicillin-resistant Staphylococcus aureus in HIV-infected patients. [21694896] Infect Drug Resist 3(-): 73-86 (2010)
2007 104	Community-associated methicillin-resistant Staphylococcus aureus infections in men who have sex with men: A case series. [18923734] Can J Infect Dis Med Microbiol 18(4): 257-61 (2007)
2008 105	The role of virulence determinants in community-associated MRSA pathogenesis. [18585915] Trends Microbiol 16(8): 361-9 (2008)
2010 106	Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. [20947620] J Antimicrob Chemother 65(12): 2658-65 (2010)
2010 107	Methicillin-resistant Staphylococcus aureus: a pervasive pathogen highlights the need for new antimicrobial development. [21165342] Yale J Biol Med 83(4): 223-33 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\MRSA.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\MRSA.php on line 92